A case of abiraterone acetate withdrawal syndrome after initiation of upfront abiraterone therapy for high-risk prostate cancer.

Masaru Tani,Yujiro Hayashi,Airi Miki,Teppei Wakita,Yuki Horibe,Yoichi Kakuta,Koichi Tsutahara,Tetsuya Takao

IJU case reports（2023）

引用 0|浏览3

暂无评分

摘要

Abiraterone acetate withdrawal syndrome was observed when hormone-sensitive prostate cancer with upfront abiraterone therapy progressed to castration-resistant prostate cancer.

查看译文

关键词

abiraterone acetate withdrawal syndrome,upfront abiraterone therapy,prostate cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要